Rybelsus Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Description

Rybelsus 3 mg tablets: Each tablet contains 3 mg semaglutide*.
Rybelsus 7 mg tablets: Each tablet contains 7 mg semaglutide*.
Rybelsus 14 mg tablets: Each tablet contains 14 mg semaglutide*.
*human glucagon-like peptide-1 (GLP-1) analogue produced in Saccharomyces cerevisiae cells by recombinant DNA technology.
Excipient with known effect: Each tablet, regardless of semaglutide strength, contains 23 mg sodium.
Excipients/Inactive Ingredients: Salcaprozate sodium, Povidone K90, Microcrystalline cellulose, Magnesium stearate.

semaglutide

Manufacturer:

Novo Nordisk

Distributor:

Zuellig Pharma